Loading organizations...
Loading organizations...
Biotechnology company
Antheia has raised $162.0M across 4 funding rounds.
Antheia has raised $162.0M in total across 4 funding rounds.
Antheia has raised $162.0M in total across 4 funding rounds.
Antheia's investors include Jeff Karras, ATHOS, Global Health Investment Corporation, Paul Ng, CFA, Joseph Lee, Civilization Ventures, Federov, In-Q-Tel, S-Cubed Capital, Sherpalo Ventures, Viking Global Investors, Hillspire.
Antheia has raised $162.0M across 4 funding rounds. Most recently, it raised $24.0M Series C Extension in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 27, 2026 | $24.0M Series C Extension | Jeff Karras, ATHOS | Global Health Investment Corporation |
| Jun 3, 2025 | $56.0M Series C | Paul Ng, CFA, Joseph Lee | ATHOS, Civilization Ventures, Federov, In-Q-Tel, S-Cubed Capital, Sherpalo Ventures, Viking Global Investors |
| Jul 1, 2021 | $73.0M Series B | Viking Global Investors | Hillspire, Sherpalo Ventures |
| $9.0M Antheia Grant | U.S. Department of Health and Human Services |